Camlin Fine Sciences Zukünftiges Wachstum
Future Kriterienprüfungen 4/6
Camlin Fine Sciences wird ein Gewinn- und Umsatzwachstum von 163.2% bzw. 15.6% pro Jahr prognostiziert, während der Gewinn pro Aktie um 163.1% pro Jahr wachsen soll.
Wichtige Informationen
163.2%
Wachstumsrate der Gewinne
163.1%
EPS-Wachstumsrate
| Chemicals Gewinnwachstum | 22.9% |
| Wachstumsrate der Einnahmen | 15.6% |
| Zukünftige Eigenkapitalrendite | n/a |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | 12 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
A Piece Of The Puzzle Missing From Camlin Fine Sciences Limited's (NSE:CAMLINFINE) 26% Share Price Climb
Nov 27
Camlin Fine Sciences (NSE:CAMLINFINE) Will Be Hoping To Turn Its Returns On Capital Around
Oct 19Camlin Fine Sciences (NSE:CAMLINFINE) Has A Somewhat Strained Balance Sheet
Mar 29Positive Sentiment Still Eludes Camlin Fine Sciences Limited (NSE:CAMLINFINE) Following 26% Share Price Slump
Mar 29Is There An Opportunity With Camlin Fine Sciences Limited's (NSE:CAMLINFINE) 31% Undervaluation?
Sep 02Is It Time To Consider Buying Camlin Fine Sciences Limited (NSE:CAMLINFINE)?
Apr 06Rainbows and Unicorns: Camlin Fine Sciences Limited (NSE:CAMLINFINE) Analysts Just Became A Lot More Optimistic
Feb 19Camlin Fine Sciences Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Nov 17Should You Think About Buying Camlin Fine Sciences Limited (NSE:CAMLINFINE) Now?
Oct 15Camlin Fine Sciences Limited (NSE:CAMLINFINE) Shares Could Be 32% Below Their Intrinsic Value Estimate
Jan 15Returns On Capital At Camlin Fine Sciences (NSE:CAMLINFINE) Paint A Concerning Picture
Jan 04Why Camlin Fine Sciences Limited (NSE:CAMLINFINE) Could Be Worth Watching
Nov 30Investors Could Be Concerned With Camlin Fine Sciences' (NSE:CAMLINFINE) Returns On Capital
Oct 05At ₹163, Is Camlin Fine Sciences Limited (NSE:CAMLINFINE) Worth Looking At Closely?
Aug 20Estimating The Intrinsic Value Of Camlin Fine Sciences Limited (NSE:CAMLINFINE)
Jun 30Camlin Fine Sciences (NSE:CAMLINFINE) Takes On Some Risk With Its Use Of Debt
Feb 26What Is Camlin Fine Sciences Limited's (NSE:CAMLINFINE) Share Price Doing?
Feb 15Is Camlin Fine Sciences Limited (NSE:CAMLINFINE) Popular Amongst Insiders?
Feb 05
Camlin Fine Sciences (NSE:CAMLINFINE) Shareholders Booked A 29% Gain In The Last Year
Jan 26Here's What To Make Of Camlin Fine Sciences' (NSE:CAMLINFINE) Returns On Capital
Jan 16Don't Ignore The Fact That This Insider Just Sold Some Shares In Camlin Fine Sciences Limited (NSE:CAMLINFINE)
Jan 06Should You Be Adding Camlin Fine Sciences (NSE:CAMLINFINE) To Your Watchlist Today?
Jan 04Can Mixed Fundamentals Have A Negative Impact on Camlin Fine Sciences Limited (NSE:CAMLINFINE) Current Share Price Momentum?
Dec 24How Should Investors React To Camlin Fine Sciences' (NSE:CAMLINFINE) CEO Pay?
Dec 13Does Camlin Fine Sciences's (NSE:CAMLINFINE) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 02Camlin Fine Sciences (NSE:CAMLINFINE) Takes On Some Risk With Its Use Of Debt
Nov 21Is Now An Opportune Moment To Examine Camlin Fine Sciences Limited (NSE:CAMLINFINE)?
Nov 09The Camlin Fine Sciences (NSE:CAMLINFINE) Share Price Is Up 49% And Shareholders Are Holding On
Oct 27What Do The Returns On Capital At Camlin Fine Sciences (NSE:CAMLINFINE) Tell Us?
Oct 14Camlin Fine Sciences Limited's (NSE:CAMLINFINE) 29% Price Boost Is Out Of Tune With Earnings
Oct 01Here's Why I Think Camlin Fine Sciences (NSE:CAMLINFINE) Might Deserve Your Attention Today
Sep 30What Kind Of Shareholders Hold The Majority In Camlin Fine Sciences Limited's (NSE:CAMLINFINE) Shares?
Sep 17Read This Before Judging Camlin Fine Sciences Limited's (NSE:CAMLINFINE) ROE
Sep 04Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 3/31/2026 | 20,627 | 772 | 1,253 | 1,273 | 1 |
| 3/31/2025 | 18,752 | 283 | -197 | 166 | 1 |
| 9/30/2024 | 16,064 | -2,231 | 1,000 | 1,609 | N/A |
| 6/30/2024 | 15,893 | -1,423 | N/A | N/A | N/A |
| 3/31/2024 | 16,131 | -928 | 784 | 1,390 | N/A |
| 12/31/2023 | 16,381 | -8 | N/A | N/A | N/A |
| 9/30/2023 | 16,400 | 350 | 283 | 785 | N/A |
| 6/30/2023 | 17,174 | 674 | N/A | N/A | N/A |
| 3/31/2023 | 16,816 | 577 | -934 | 509 | N/A |
| 12/31/2022 | 16,441 | 581 | N/A | N/A | N/A |
| 9/30/2022 | 16,371 | 628 | -1,333 | 1,007 | N/A |
| 6/30/2022 | 14,650 | 442 | N/A | N/A | N/A |
| 3/31/2022 | 14,121 | 650 | -683 | 1,454 | N/A |
| 12/31/2021 | 13,495 | 598 | N/A | N/A | N/A |
| 9/30/2021 | 12,666 | 465 | -544 | 1,050 | N/A |
| 6/30/2021 | 12,122 | 579 | N/A | N/A | N/A |
| 3/31/2021 | 11,871 | 510 | 335 | 1,174 | N/A |
| 12/31/2020 | 11,533 | 394 | N/A | N/A | N/A |
| 9/30/2020 | 11,293 | 291 | 540 | 1,165 | N/A |
| 6/30/2020 | 10,948 | 302 | N/A | N/A | N/A |
| 3/31/2020 | 10,491 | 303 | -481 | 860 | N/A |
| 12/31/2019 | 10,243 | 349 | N/A | N/A | N/A |
| 9/30/2019 | 9,918 | 277 | -1,131 | 424 | N/A |
| 6/30/2019 | 9,709 | 221 | N/A | N/A | N/A |
| 3/31/2019 | 8,922 | 6 | -783 | -90 | N/A |
| 12/31/2018 | 8,523 | -139 | N/A | N/A | N/A |
| 9/30/2018 | 8,186 | -222 | N/A | N/A | N/A |
| 6/30/2018 | 7,634 | -277 | N/A | N/A | N/A |
| 3/31/2018 | 7,206 | -338 | N/A | -154 | N/A |
| 12/31/2017 | 6,403 | -367 | N/A | N/A | N/A |
| 9/30/2017 | 5,676 | -311 | N/A | N/A | N/A |
| 6/30/2017 | 5,347 | -275 | N/A | N/A | N/A |
| 3/31/2017 | 5,339 | -128 | N/A | -87 | N/A |
| 12/31/2016 | 5,149 | 98 | N/A | N/A | N/A |
| 9/30/2016 | 5,013 | 174 | N/A | N/A | N/A |
| 6/30/2016 | 5,063 | 232 | N/A | N/A | N/A |
| 3/31/2016 | 4,893 | 358 | N/A | 716 | N/A |
| 12/31/2015 | 5,083 | 445 | N/A | N/A | N/A |
| 9/30/2015 | 5,238 | 463 | N/A | N/A | N/A |
| 6/30/2015 | 5,531 | 552 | N/A | N/A | N/A |
| 3/31/2015 | 5,583 | 550 | N/A | 463 | N/A |
| 3/31/2014 | 5,087 | 287 | N/A | 267 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: CAMLINFINE wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (6.7%).
Ertrag vs. Markt: CAMLINFINE wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.
Hohe Wachstumserträge: CAMLINFINE wird voraussichtlich in den nächsten 3 Jahren rentabel werden.
Einnahmen vs. Markt: CAMLINFINEDie Einnahmen des Unternehmens (15.6% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (10.4% pro Jahr).
Hohe Wachstumseinnahmen: CAMLINFINEDie Einnahmen des Unternehmens (15.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von CAMLINFINE in 3 Jahren voraussichtlich hoch sein wird